These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 33952812
1. Atorvastatin Reduces Circulating S100A12 Levels in Patients with Carotid Atherosclerotic Plaques - A Link with Plaque Inflammation. Komatsu T, Ayaori M, Uto-Kondo H, Hayashi K, Tamura K, Sato H, Sasaki M, Nishida T, Takiguchi S, Yakushiji E, Nakaya K, Ikewaki K. J Atheroscler Thromb; 2022 May 01; 29(5):775-784. PubMed ID: 33952812 [Abstract] [Full Text] [Related]
2. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study. Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS. J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083 [Abstract] [Full Text] [Related]
3. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18F-FDG PET/CT imaging study. Kang MK, Kim CJ, Choo EH, Han EJ, Hwang BH, Kim JJ, Kim SH, O JH, Chang K. Int J Cardiovasc Imaging; 2019 Sep 03; 35(9):1745-1753. PubMed ID: 31312997 [Abstract] [Full Text] [Related]
4. Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease. Hoogeveen RM, Verweij SL, Kaiser Y, Kroon J, Verberne HJ, Vogt L, Moens SJB, Stroes ESG. Sci Rep; 2021 Feb 18; 11(1):4126. PubMed ID: 33602971 [Abstract] [Full Text] [Related]
5. Effect of moderate-intensity statin therapy on plaque inflammation in patients with acute coronary syndrome: A prospective interventional study evaluated by 18F-FDG PET/CT of the carotid artery. Kim CJ, Han EJ, Chu EH, Hwang BH, Kim JJ, Seung KB, Kim SH, O JH, Chang K. Cardiol J; 2020 Feb 18; 27(6):762-771. PubMed ID: 30009378 [Abstract] [Full Text] [Related]
6. Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlr-/-Apob100/100 mice. Hellberg S, Sippola S, Liljenbäck H, Virta J, Silvola JMU, Ståhle M, Savisto N, Metso J, Jauhiainen M, Saukko P, Ylä-Herttuala S, Nuutila P, Knuuti J, Roivainen A, Saraste A. Atherosclerosis; 2017 Aug 18; 263():369-376. PubMed ID: 28457625 [Abstract] [Full Text] [Related]
7. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH, Tian P, Xu JP, Wang ZZ, Zhao XZ, Nie MX, Zhang MD, Zhao QM, Zhao BT, Song SJ. Zhonghua Nei Ke Za Zhi; 2019 Nov 01; 58(11):808-813. PubMed ID: 31665855 [Abstract] [Full Text] [Related]
8. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial. Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A. Atherosclerosis; 2015 Jun 01; 240(2):490-6. PubMed ID: 25913664 [Abstract] [Full Text] [Related]
9. High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. Subramanian S, Emami H, Vucic E, Singh P, Vijayakumar J, Fifer KM, Alon A, Shankar SS, Farkouh M, Rudd JHF, Fayad ZA, Van Dyke TE, Tawakol A. J Am Coll Cardiol; 2013 Dec 24; 62(25):2382-2391. PubMed ID: 24070911 [Abstract] [Full Text] [Related]
10. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study. Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA. JACC Cardiovasc Imaging; 2013 Oct 24; 6(10):1087-1094. PubMed ID: 24135322 [Abstract] [Full Text] [Related]
11. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T. Clin Ther; 2010 Dec 24; 32(14):2337-47. PubMed ID: 21353104 [Abstract] [Full Text] [Related]
12. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial. Boczar KE, Shin S, deKemp RA, Dowlatshahi D, Tavoosi A, Wiefels C, Liu P, Lochnan H, MacPherson PA, Chong AY, Torres C, Leung E, Tawakol A, Ahmadi A, Garrard L, Lefebvre C, Kelly C, MacPhee P, Tilokee E, Raggi P, Wells GA, Beanlands R. BMJ Open; 2023 Nov 10; 13(11):e074463. PubMed ID: 37949621 [Abstract] [Full Text] [Related]
13. In vivo evaluation of atherosclerotic plaque inflammation and of anti-inflammatory effects of statins by 18F-fluorodeoxyglucose positron emission tomography. Gerber BL. J Am Coll Cardiol; 2013 Sep 03; 62(10):918-20. PubMed ID: 23727087 [No Abstract] [Full Text] [Related]
14. Effect of Pioglitazone in Combination with Moderate Dose Statin on Atherosclerotic Inflammation: Randomized Controlled Clinical Trial Using Serial FDG-PET/CT. Choo EH, Han EJ, Kim CJ, Kim SH, O JH, Chang K, Seung KB. Korean Circ J; 2018 Jul 03; 48(7):591-601. PubMed ID: 29968431 [Abstract] [Full Text] [Related]
15. Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A. Circ Cardiovasc Imaging; 2016 Dec 03; 9(12):e004195. PubMed ID: 27956407 [Abstract] [Full Text] [Related]
16. A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review. Kadoglou NP, Khattab E, Velidakis N, Patsourakos N, Lambadiari V. Kardiol Pol; 2022 Dec 03; 80(9):880-890. PubMed ID: 35734817 [Abstract] [Full Text] [Related]
17. Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by 18F-FDG PET/CT. Kaida H, Tahara N, Tahara A, Honda A, Nitta Y, Igata S, Ishibashi M, Yamagishi S, Fukumoto Y. Atherosclerosis; 2014 Dec 03; 237(2):404-9. PubMed ID: 25463065 [Abstract] [Full Text] [Related]
18. Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. Vucic E, Calcagno C, Dickson SD, Rudd JH, Hayashi K, Bucerius J, Moshier E, Mounessa JS, Roytman M, Moon MJ, Lin J, Ramachandran S, Tanimoto T, Brown K, Kotsuma M, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2012 Aug 03; 5(8):819-28. PubMed ID: 22897996 [Abstract] [Full Text] [Related]
19. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, Hayabuchi N, Imaizumi T. J Am Coll Cardiol; 2006 Nov 07; 48(9):1825-31. PubMed ID: 17084257 [Abstract] [Full Text] [Related]